Patient Compliance

Provinces and territories determine not only the drugs to be reimbursed in their jurisdiction but also the conditions under which people can access them.

'Revocation ensures that the registrant cannot use his status as a licensed physician to bolster the credibility of his COVID-19 communications,' wrote the Ontario Physicians and Surgeons Discipline Tribunal in its penalty decision for Dr. Mark Trozzi.

We're looking to speak with pharmacists who are feeling the pressure to push clinical services.

Do these drugs point toward a root cause of metabolic disease? What inspired their development in the first place?

Got a story to tell? Send it in for consideration to run in the Medical Post magazine’s Stories Issue in December.

The change is set to come into effect Jan. 31, 2024.

Study examines whether exposure to stimulant medications for attention deficit hyperactivity disorder during pregnancy affects childhood neurodevelopment.

See what your colleagues say. Take our weekly doctor poll.